Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Knowing when to use cash back versus rewards points can enhance your savings. Our guide provides insights for better decision-making.
26,047 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A new breed of boutique VC funds merges capital with deep operator networks, embracing a village mindset as founders ...
As earnings season looms, Monday’s best Wall Street calls are guiding early moves in key names. Traders watch multipl...
Three giants of U.S. banking posted strong Q1 results, yet each faces a different market reality. JPMorgan sits near ...
Cisco stock is at a pivotal crossroads as AI infrastructure demand accelerates. This article weighs targets, catalyst...
Two lesser-known robotics stocks beat earnings, underscoring a broader wave of AI-powered automation beyond the famil...
Three u.s. military service members were killed in an Iran operation, CENTCOM says. The move sent ripples through ene...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
Tensions with Iran are driving a puzzling market mix: gold retreats while equities slip only modestly, hinting at a b...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
Trump heads Beijing high-stakes summit as markets watch for any change in US-China policy on crypto, potentially resh...